| heal.abstract |
We synthesized four derivatives of 17 beta-estradiol (E2) with an azide substitution on a 17 alpha-side chain of varying length, namely 17 alpha-(azidopropargyl)-3,17 beta-estradiol (5), its 17 beta-azido derivative (diazide 7), 17 alpha-(5-azido-pent-1-ynyl)-3,17 beta-estradiol (6) and 17 alpha-(azidopentyn-2-yl)-3,17 beta-estradiol (10). While most of the derivatives had low (7) or marginal (6 and 10) relative binding affinity (RBA) for both types of estrogen receptor (ER alpha and ER beta), the RBA alpha and RBAP of 5 were practically identical to those of E2. The estrogenic activity of the derivatives was assessed using estrogen-responsive breast (MCF-7) and endometrial cancer (Ishikawa) cells. While 5 was a potent and effective inducer of alkaline phosphatase in Ishikawa cells and 7 was less potent but as effective as 5,6 was marginally active and 10 was totally inactive in this respect. In the presence of 0.1 nM E2, however, 6 exhibited some ER antagonist activity at the highest concentration tested (1 mu M). Similar results were obtained as regards the potency and efficacy of stimulation of MCF-7 cell proliferation and induction of luciferase gene expression in MCF-7:D5L cells, a clone stably transfected with an estrogen-responsive form of the gene. These data suggest that, while 5, 6, 7 and 10 interact with either type of ER in isolation, only 5 and 7 exhibit substantial ER agonist activity in the different estrogen-target cells examined, which could provide for photoaffinity labelling of the receptor in the cell as well as in isolation. (c) 2005 Elsevier Inc. All rights reserved. |
en |